The Journal of Japan Atherosclerosis Society
Online ISSN : 2185-8284
Print ISSN : 0386-2682
ISSN-L : 0386-2682
Alteration of Serum Amyloid A Protein (SAA) in High Density Lipoproteins in Patients with Acute Myocardial Infarction
Yoshitaka KUMONKenzo YOSHIDATadashi SUEHIROFumitoshi OHNO
Author information
JOURNAL OPEN ACCESS

1987 Volume 15 Issue 5 Pages 1197-1206

Details
Abstract
Serum amyloid A protein (SAA) was prepared and purified by gel filtration from high density lipoprotein (HDL) obtained from the pooled plasma of patients with bronchiectasis and rheumatoid arthritis. Rabbits were repeatedly immunized with SAA, and the resulting antiserum IgG was rendered monospecific to apo SAA by absorption with normal human HDL and VLDL. Immunoblot analysis, using this monospecific anti-SAA, demonstrated the presence of apo SAA in HDL fractions obtained from the patients with acute myocardial infarction. Two-dimensional gel electrophoresis demonstrated the presence of 6 apo SAA isoforms with a molecular weight of approximately 12, 000, and two major isoelectric points of 6.3 and 5.9. Apo SAA in HDL fractions was determined during the course of acute myocaldial infarction. The apo SAA/apo A-I ratio increased sharply and peaked on the 3rd and 5th days after onset, with 0.90±0.58 (up to 1.68), and declined to an almost normal level on the 10th day. On the other hand, the decrease in plasma apo A-I/HDL-C and apo A-II/HDL-C ratio on the 3rd and 5th days was observed. And during the course, the apo SAA/apo A-I ratio in HDL correlated inversely with the plasma apo A-I/HDL-C and apo A-II/HDL-C ratio (r=-0.538; p<0.001, r=-0.566; p<0.001). In view of these results, the possibility that apo SAA as a constituent of HDL particles might actually change places with apo A-I and apo A-II was suggested. We conclude that these apo SAA-enriched HDL particles, i. e., a remodeled apolipoprotein structure, not only yield abnormal HDL metabolism but also may affect the metabolism of the other lipoproteins.
Content from these authors
© Japan Atherosclerosis Society

This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-nc-sa/4.0/
Previous article Next article
feedback
Top